Australia’s only Q fever vaccine runs out this week, a year after cases hit a record high
Australia is expected to run out of Q-VAX, the country's only human Q fever vaccine, this week. Its maker, CSL Seqirus, says three or four batches could not be released after raw-material and equipment problems, and the next two are not expected until late December. It leaves farmers, shearers, meat workers and vets unable to get a jab against a disease that hit a record 991 Australians last year.
Updates
- 3.29am AWSTLatest
CSL Seqirus confirms Q-VAX will be out of stock from this week until about late December, after three or four batches could not be released.
Three things to know
- Q-VAX is the only human Q fever vaccine and CSL Seqirus is its only maker; the company is apologising for a "short temporary stock out" until the end of the year.
- Each batch takes about nine months to make, so a failed batch cannot be quickly replaced: three or four were lost in the past 12 months.
- The national medicines regulator has listed Q-VAX in short supply since January, and its listing runs to 31 January 2027.
Australia’s supply of Q fever vaccine is expected to run dry this week, leaving the people most exposed to the disease, from dairy farmers to shearers and abattoir staff, with nowhere to get protected until at least late December.
CSL Seqirus, which makes Q-VAX in Melbourne under contract to the federal government, says it expects “a short temporary stock out” from now until the end of the year. Chris Larkins, the company’s senior vice-president of operations, said its next two batches had been expedited and should be ready around late December. He apologised and said stabilising supply was the company’s top priority.
Why can’t they just make more?
Because the vaccine takes most of a year to make. Mr Larkins said each batch takes about nine months, and is made with an inactivated form of the bacterium that causes the disease.
Over the past 12 months, he said, problems with the supply of raw materials and unexpected failures in the equipment on its filling line meant three or four batches could not be released. He said he expects supply to stay tight until late this year or early next, and to improve once production moves to two new sites in Melbourne.
The Therapeutic Goods Administration’s medicine-shortage register has listed Q-VAX as in limited availability since 12 January this year, citing manufacturing, with the shortage expected to last until 31 January 2027. It says the sponsor is closely controlling supply.
Who is left exposed?
Q fever is caught from animals, mostly cattle, sheep and goats, often by breathing in dust contaminated by birth fluids, urine or dung. It can cause a severe flu-like illness, and some people are left with long-term fatigue or heart problems. Vaccination is routinely required for many meat processing workers, and is strongly recommended for farmers, shearers, vets and others who work with livestock.
Those are the people now waiting. A dairy farmer at Rawsonville, in central-west NSW, said she had not been able to vaccinate her staff since March. A nurse who also works as a shearer said she waited about five years for a vaccine after starting shearing in 2020. “People want it and need it and it will save lives,” she said.
How bad is Q fever right now?
Australia recorded 991 Q fever cases last year, the highest number since national monitoring began in 1991. A stock-out during the busiest disease year in a generation means workers who have not yet been vaccinated will go through spring and early summer without protection.
Hasn’t this happened before?
Yes. Q-VAX was in short supply from May 2024 into early 2025, when doses were rationed to the highest-risk workers before CSL Seqirus said supply had returned to normal in February 2025. This time there will be no doses at all for several weeks.
Who is responsible for supply?
A Department of Health spokesperson said CSL Seqirus manages the manufacture and commercial supply of Q-VAX, including distribution and how available stock is allocated. The spokesperson said the department’s arrangement with the company runs over 10 years and is worth $1 billion, and that it supports keeping the ability to make vaccines in Australia.
VNN will update this story as more is confirmed.
How we got here
The key moments that brought this story into focus. Open any moment for detail.
1991National Q fever monitoring begins
Cases are tracked across Australia from this year.
May 2024Q-VAX shortage
Supply is restricted to the highest-risk workers.
February 2025Supply returns
CSL Seqirus says Q-VAX supply is back to normal.
2025Record year
Australia records 991 Q fever cases, the most since 1991.
12 January 2026Shortage listed again
The TGA lists Q-VAX in limited availability, citing manufacturing.
12 November 2026Stock-out
CSL Seqirus says supply will run out this week until late December.
What happens next
CSL Seqirus expects its next two batches around late December, with supply staying tight into early 2027. The TGA's shortage listing runs to 31 January 2027. Workers who need the vaccine should speak to their GP or vaccine provider about when stock returns; the vaccine requires a pre-vaccination skin and blood test first.
Sources
- VNN
VNN never names people who give us information in confidence. How we protect sources and tips.
That is the story in a minute. For the evidence, context and what happens next, switch to the full story.
Weather today
Saturday 14 November
Perth
Warm with storms nearby · 20% rain
26°17°
A warm Saturday for Perth with storms on the horizon; Sydney heats up, Hong Kong gets soaked, and London and New York stay cold.
- Sydney30°19°
- Melbourne17°13°
- Brisbane25°21°
- Adelaide18°13°
- Auckland20°13°
- Singapore29°25°
More cities (12)
- Tokyo19°11°
- Hong Kong27°22°
- Mumbai32°23°
- Dubai29°22°
- Nairobi24°14°
- Lagos31°25°
- Johannesburg29°19°
- London8°1°
- Paris9°2°
- New York7°2°
- Los Angeles21°15°
- Toronto6°2°
Highs and lows in °C, local time.
Breaking now
Live deskDeveloping stories
Live deskStories we’re following
Live deskMost read this week
For subscribers
Read every subscriber story in full, on any device. Premium reports are sold separately.
Secure payment · Cancel anytime · Subscribers sign in
Markets
Stocks
- Alphabet (GOOGL)Nasdaq295.77 USDdown -0.98%
- Amazon (AMZN)Nasdaq266.66 USDdown -0.29%
- Apple (AAPL)Nasdaq356.27 USDup +0.39%
- ASX 200ASX9,082.20down -0.71%
- Berkshire Hathaway (BRK.B)NYSE592.94 USDup +0.53%
- BHP Group (BHP)ASX58.86 AUDdown -1.26%
Currencies
- AUD/EURForex0.615300 EURdown -0.36%
- AUD/GBPForex0.514200 GBPdown -0.33%
- AUD/JPYForex108.8100 JPYdown -0.43%
- AUD/NZDForex1.227300 NZDdown -0.32%
- AUD/USDForex0.680400 USDdown -0.54%
- BTC/USDCrypto68,241.00 USDdown -4.59%
As at 14 Nov 2026, 5:52 am GMT+0800. Entered by VNN. Not financial advice.
For you
Follow the topics you care about and save stories with the bookmark. They gather here, on this device only.
Saved on this device only. Nothing is sent to VNN.
Help keep the lights on.
Independent news costs money to make and nothing to read. Chip in and keep it that way.
ContributeFrom A$5 a month · Cancel anytimeThe daily briefing
Start informed.
The essential headlines, the useful context and what to watch next, in your inbox each morning.







Comments
0 commentsCommunity rules
To read and join the conversation, please agree to our rules.
You have agreed to the community rules.
No comments yet. Start the conversation.